About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Nos2tm1Liew
targeted mutation 1, Foo Y Liew
MGI:2158787
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Nos2tm1Liew/Nos2tm1Liew involves: 129 * 129P2/OlaHsd MGI:4358423
hm2
Nos2tm1Liew/Nos2tm1Liew involves: 129P2/Ola * MF1 MGI:2672126


Genotype
MGI:4358423
hm1
Allelic
Composition
Nos2tm1Liew/Nos2tm1Liew
Genetic
Background
involves: 129 * 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nos2tm1Liew mutation (0 available); any Nos2 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• macrophage killing of Calmette-Guerin mycobacteria following ATP stimulation is normal




Genotype
MGI:2672126
hm2
Allelic
Composition
Nos2tm1Liew/Nos2tm1Liew
Genetic
Background
involves: 129P2/Ola * MF1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nos2tm1Liew mutation (0 available); any Nos2 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• in vitro, splenocytes from L. major-infected homozygotes display significantly higher levels of T cell proliferation in response to leishmanial antigens or ConA than those from similarly-infected wild-type or heterozygous mice
• homozygotes infected with L. major exhibit a significantly stronger Th1 type of immune response than similarly-infected wild-type or heterozygous mice
• in vitro, splenocytes from L. major-infected homozygotes produce more IFN-gamma but less IL-4 in response to soluble leishmania antigens than those from similarly-infected wild-type or heterozygous mice
• in addition, splenocytes from carrageenin-treated homozygotes produce more IFN-gamma than those from similarly-treated wild-type mice when stimulated with ConA
• in the carrageenin-induced paw-edema model, homozygotes develop significantly less footpad swelling than similarly-treated wild-type mice
• unlike wild-type mice which display up to 12% loss of mass and ~50% mortality by 48 hr after LPS treatment (12.5 mg/kg), all homozygotes are shown to fully recover from an initial transient loss of mass within the first 24 hrs
• unlike wild-type and heterozygous mice which are highly resistant to Leishmania major infection and achieve spontaneous healing after footpad injection, homozygotes display higher parasite loads and develop visceral disease by day 70 post-infection, as indicated by a 2- to 3-fold increase in spleen and draining lymph node size

hematopoietic system
• in vitro, splenocytes from L. major-infected homozygotes display significantly higher levels of T cell proliferation in response to leishmanial antigens or ConA than those from similarly-infected wild-type or heterozygous mice
• homozygotes infected with L. major exhibit a significantly stronger Th1 type of immune response than similarly-infected wild-type or heterozygous mice

cellular
• in vitro, splenocytes from L. major-infected homozygotes display significantly higher levels of T cell proliferation in response to leishmanial antigens or ConA than those from similarly-infected wild-type or heterozygous mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory